| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
06.12.2017 US 201762595348 P
06.12.2017 US 201762595357 P
24.05.2018 US 201815988311
24.05.2018 US 201862675972 P
24.05.2018 WO PCT/US2018/034334
23.08.2018 US 201816109875
23.08.2018 US 201816109897
23.08.2018 US 201862721644 P
|
| (71) |
Applicant: Pandion Therapeutics, Inc. |
|
Cambridge, Massachusetts 02139 (US) |
|
| (72) |
Inventors: |
|
- HIGGINSON-SCOTT, Nathan
Cambridge, Massachusetts 02139 (US)
- VINEY, Joanne L.
Cambridge, Massachusetts 02139 (US)
- VISWESWARAIAH, Jyothsna
Cambridge, Massachusetts 02139 (US)
- SAMPSON, Erik Robert
Cambridge, Massachusetts 02139 (US)
- OTIPOBY, Kevin Lewis
Cambridge, Massachusetts 02139 (US)
|
| (74) |
Representative: HGF |
|
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB) |
|
